Breast cancer (Tokyo, Japan)

· 3 papers in corpus
review 2025
Emerging roles of KIR2DL4 in cancer immunotherapy
doi:10.1007/s12282-025-01738-y ·PMID:40549069

Killer-cell immunoglobulin-like receptor 2DL4 (KIR2DL4), a member of the killer cell immunoglobulin-like receptors (KIRs) family, plays an important role in the regulation of the immune system, which is expressed primarily on natural killer…

observational 2017
Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis
doi:10.1007/s12282-016-0746-8 ·PMID:27943163

BACKGROUND: Atypical femoral fracture (AFF) occurs with minor trauma in patients receiving antiresorptive drugs such as bisphosphonate and denosumab. We hypothesized that patients with bone metastasis who receive higher doses of antiresorpt…

rct 2016
A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer
doi:10.1007/s12282-015-0593-z ·PMID:25655898

BACKGROUND: Luteinizing hormone-releasing hormone (LH-RH) agonists provide effective adjuvant treatment for premenopausal women with endocrine-responsive breast cancer. Here, we investigated appropriate treatment durations of an LH-RH agoni…